Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00241826 · ClinicalTrials.gov registry record

Prospective Investigation of Pulmonary Embolism Diagnosis III

A clinical trial of Pulmonary Embolism and Lung Diseases, sponsored by George Washington University.

Completed
Registry status
1,256
Enrollment target
9
Study locations

NCT00241826 is a study of Pulmonary Embolism and Lung Diseases that has completed, run by George Washington University. The registered enrollment target is 1,256 participants, below the 3,032-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (59% lower). The trial reports 9 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00241826, a study of Pulmonary Embolism and Lung Diseases, has completed, sponsored by George Washington University.

COMPLETED
Registry status
1,256 participants
Enrollment target
9
Study locations

Study Summary

The purpose of this study is to determine the diagnostic accuracy of gadolinium-enhanced magnetic resonance angiography (Gd-MRA) of the pulmonary arteries in combination with magnetic resonance venography (MRV) of the veins of the thighs in patients with clinically suspected acute pulmonary embolism (PE).

Conditions Studied

Pulmonary Embolism Lung Diseases

Interventions

  • PROCEDURE Magnetic Resonance Angiography
  • PROCEDURE Magnetic Resonance Venography

Study Locations (9)

Maryland

  • Divison of Lung Diseases, NHLBI - Bethesda
  • Data Coordinating Center - Rockville

Michigan

  • University of Michigan Medical Center - Ann Arbor
  • St. Joseph Mercy-Oakland - Pontiac

Georgia

  • Emory University - Atlanta

Massachusetts

  • Massachusetts General Hospital - Boston

Missouri

  • Washington University Medical Center - St Louis

New York

  • NYU Medical Center - New York

Alberta

  • Foothills Hospital - Calgary

Trial Details

FieldValue
Enrollment Target 1,256 participants
Start Date 2006-04
Est. Completion 2009-04

Sponsor

George Washington University

133 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00241826

The ClinicalTrials.gov registry entry for NCT00241826 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,256 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,032-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (59% lower). The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Angiography is the first listed.

NCT00241826 reports 9 study locations spanning 7 distinct geographic areas - top geographies include Maryland, Michigan, Georgia.

Frequently Asked Questions

What is clinical trial NCT00241826 about?

NCT00241826 is a clinical study titled "Prospective Investigation of Pulmonary Embolism Diagnosis III". The purpose of this study is to determine the diagnostic accuracy of gadolinium-enhanced magnetic resonance angiography (Gd-MRA) of the pulmonary arteries in combination with magnetic resonance venography (MRV) of the veins of the thighs in patients with clinically suspected acute pulmonary embolism...

What is the current status of trial NCT00241826?

This trial is currently completed. The enrollment target is 1,256 participants. The study started on 2006-04. Estimated completion is 2009-04.

What conditions does trial NCT00241826 study?

This clinical trial studies the following conditions: Pulmonary Embolism, Lung Diseases.

What interventions are being tested in trial NCT00241826?

The interventions under investigation include: Magnetic Resonance Angiography (PROCEDURE), Magnetic Resonance Venography (PROCEDURE).

Who is sponsoring clinical trial NCT00241826?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00241826 being conducted?

This trial has 9 study locations across Georgia, Maryland, Massachusetts, Michigan, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pulmonary Embolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pulmonary Embolism

All registered trials for this condition

Lung Diseases

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.